CRYSTAL FOR ORAL SOLID DRUG AND ORAL SOLID DRUG FOR DYSURIA TREATMENT CONTAINING THE SAME

• 收藏
• 分享

专利权人:

Kissei Pharmaceutical Co Ltd

发明人:

申请号：

NO2011011

公开号：

NO2011011I2

申请日:

2011.07.11

申请国别(地区):

NO

年份:

2012

代理人:

摘要：

A crystal for oral solid medicament comprised of indoline compound (KMD-3213) which exerts alpha 1-adrenaline receptor blocking effect, is useful as a therapeutic agent for dysuria and is represented by the formula: (I) wherein in the powder X-ray diffraction pattern, the compound is characterized by main peaks of 5.5 DEG +/- 0.2 DEG , 6.1 DEG +/- 0.2 DEG , 9.8 DEG +/- 0.2 DEG , 11.1 DEG +/- 0.2 DEG , 12.2 DEG +/- 0.2 DEG , 16.4 DEG +/- 0.2 DEG , 19.7 DEG +/- 0.2 DEG and 20.0 DEG +/- 0.2 DEG as 2&thetas；. There is further provided an oral solid medicament for dysuria treatment containing the crystal as an active ingredient. <；CHEM>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/